XML 245 R98.htm IDEA: XBRL DOCUMENT
v3.25.1

Summary of Significant Accounting Policies - Schedule of Securities that were Excluded from the Diluted Per Share (Details) - shares | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Mar. 31, 2024 | Dec. 31, 2024 | Dec. 31, 2023
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities |  | 5,384,113 |  | 451,986 |  | 2,169,030 |  | 414,659 |
Options to purchase common stock [Member] |  |  |  |  |  |  |  |  |
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities |  | 1,451,425 |  | 47,287 |  | 52,479 |  | 56,880 |
Warrants to purchase common stock [Member] |  |  |  |  |  |  |  |  |
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities |  | 171,163 |  | 60,562 |  | 182,996 |  | 43,035 |
Series A Preferred Stock [Member] |  |  |  |  |  |  |  |  |
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities |  |  | [1] | 60,000 | [1] | 60,000 | [2] | 60,000 | [2]
Series B Preferred Stock [Member] |  |  |  |  |  |  |  |  |
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities |  |  | [3] | 194,004 | [3] | 194,004 | [4] | 194,004 | [4]
Series C Preferred Stock [Member] |  |  |  |  |  |  |  |  |
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities |  | 1,452,282 | [5] |  | [5] | 1,452,282 | [6] |  | [6]
Series D Preferred Stock [Member] |  |  |  |  |  |  |  |  |
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities | [7] | 2,074,689 |  |  |  |  |  |  |
Convertible notes [Member] |  |  |  |  |  |  |  |  |
Schedule of Summarizes the Securities that were Excluded from the Diluted Per Share [Line Items] |  |  |  |  |  |  |  |  |
Potentially dilutive securities |  | 234,554 | [8] | 90,133 | [8] | 227,269 | [9] | 60,740 | [9]
[1] | Assumed the Series A convertible preferred stock (“Series A Preferred Stock”) was converted into shares of common stock of the Company at a conversion price of $150.00 per share.
[2] | Assumed the Series A convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $150.00 per share.
[3] | Assumed the Series B convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $56.70 per share.
[4] | Assumed the Series B convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $56.70 per share.
[5] | Assumed the Series C convertible preferred stock (“Series C Preferred Stock”) was converted into shares of common stock of the Company at a conversion price of $2.41 per share.
[6] | Assumed the Series C convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.
[7] | Assumed the Series D convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.
[8] | Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $11.25 per share for the three months ended March 31, 2025. Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $67.50 and $22.50 and $15.00 per share for the three months ended March 31, 2024.
[9] | Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $11.25 per share for the year ended December 31, 2024. Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $67.50 and $22.50 per share for the year ended December 31, 2023.

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=avco_OptionsToPurchaseCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesCPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_SeriesDPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |